Live Breaking News & Updates on Molecular Tumor|Page 15

Stay updated with breaking news from Molecular tumor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

NanoString Technologies : Launches Technology Access Program for the Spatial Molecular Imager (SMI) Platform and Showcases Spatially Resolved Transcriptomic Research at 2021 Advances in Genome Biology and Technology (AGBT) Conference


Message :
Required fields
Data in Twenty-One Poster and Oral Presentations Highlight use of GeoMx Digital Spatial Profiler and the Spatial Molecular Imager Platform for Discovery and Translational Applications
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the launch of a Technology Access Program (TAP) for the Spatial Molecular Imager. Under the program, a customer can submit tissue samples to NanoString to be analyzed using the 1000-plex RNA panel and receive a complete data package. Researchers interested in participating in NanoString’s Technology Access Program should contact the company at [email protected]. ....

United States , Dana Farber Cancer Institute , Chris Mason , Brad Gray , Joe Beechem , Christopher Mason , Matthewl Freedman , Transcriptome Atlas , Alex Swarbrick , Technology Access Program , Nanostring Technologies Inc , Garvin Institute , Nanostring Technology Access Program , Nanostring Technologies , Spatial Molecular , Digital Spatial Profiler , Whole Transcriptome Atlas , Geomx Whole Transcriptome , Geomx Whole Transcriptome Atlas , Spatial Molecular Imager , Weill Cornell Medicine , Nanostring Corporate Workshop , Gold Sponsor Workshop , String Technologies , Analysis System , Counter Analysis System ,

Molecular Stethoscope Announces Publication of its NAFLD/NASH Study in the American Journal of Physiology


(1)
Circulating cell-free mRNA in blood reflective of NAFLD/NASH liver pathology
PALO ALTO, Calif., Feb. 23, 2021 /PRNewswire/ Molecular Stethoscope, Inc., a precision medicine biotechnology company, announces publication of its human proof-of-concept study describing the stratification of NAFLD/NASH patients with clinically relevant and advanced liver fibrosis using the company s Next-Generation cell-free mRNA Liquid Biopsy Technology Platform. The study titled Non-invasive Stratification of Non-Alcoholic Fatty Liver Disease by Whole-transcriptome Cell-free mRNA Characterization was published in the
American Journal of Physiology -
Gastrointestinal and Liver Physiology, a journal of the American Physiological Society. The first author is Naga Chalasani, M.D., Professor of Gastroenterology and Hepatology and Interim Chair in the Department of Medicine at Indiana University in the USA. Dr. Chalasani is the leading author of the AASLD Practice Guidelines for th ....

Stanford University , United States , Stephen Quake , Guillermo Elias , Chan Zuckerberg Biohub , Kostenloser Wertpapierhandel , Veronica Miller , Naga Chalasani , Eric Topol , Scripps Research Translational Institute , Uc Berkeley School Of Public Health , Technology Platform , Prnewswire Molecular Stethoscope Inc , Drug Development Tools , Molecular Stethoscope Technology Platform , Forum For Collaborative Research , United States National Institute Of Standards , Rna Liquid Biopsy Technology Platform , Liver Forum , Professor Of Bioengineering At Stanford University , American Physiological Society , Artificial Intelligence Technology Platform , Department Of Medicine At Indiana University , Biopsy Technology , Non Alcoholic Fatty Liver Disease , Whole Transcriptome Cell Free ,